References
- Leiss O, von Bergmann K. Rezidivprophylaxe nach erfolgter Galiensteinauflosung. Z Gastroenterol 1991; 29: 301–5
- Jacyna M R. Interactions between gallbladder bile and mucosa: relevance to gallstone formation. Gut 1990; 31: 568–70
- Dowling R H. Gallstone prevention after successful treatment. Gallstone disease. Pathophysiology and therapeutic approaches, W Swobodnik, H Ditschuneit, R D. Soloway. Springer Verlag, Berlin 1990; 237–8
- Niederau C, Strohmeyer G. Pathophysiologie der Bildung von Gallenstein-Rezidiven. Chirurg 1990; 61: 359–64
- Riemann J F., Adamek H E., Weber J. Piezoelectric lithotripsy in the treatment of symptomatic gallstone patients. J Clin Gastroenterol 1991; 13: 395–400
- Sackmann M, Delius M, Sauerbruch T, et al. Shock-wave lithotripsy of gallbladder stones. The first 175 patients. N Engl J Med 1988; 318: 393–7
- Sackmann M, Ippisch E, Sauerbruch T, et al. Early gallstone recurrence rate after successful shock-wave therapy. Gastroenterology 1990; 98: 392–6
- Lee S P., LaMont J T., Carey M C. Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones. J Clin Invest 1981; 67: 1712–23
- Robertson R P. Prostanoids and eicosanoids: arachidonic and metabolites relevant to medicine. Harrison's principles of internal medicine. 10th ed., R G. Petersdorf, R D. Adams, E Braunwald, K J. Isselbacher, J B. Martin, J D. Wilson. McGraw Hill, New York 1983; 482–7
- Kaminski D L. Arachidonic acid metabolites in hepatobiliary physiology and disease. Gastroenterology 1989; 97: 781–92
- Lee S P., Carey M C., LaMont J T. Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 1981; 211: 1429–31
- Hood K, Gleeson D, Ruppin D C., et al. Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs. Lancet 1988; 2: 1223–5
- Broomfield P H., Chopra R, Sheinbaum R C., et al. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 1988; 319: 1567–72
- Catnach S M., Fairclough P D., Trembath R C., et al. Effect of oral erythromycin on gallbladder motility in normal subjects and subjects with gallstones. Gastroenterology 1992; 102: 2071–6
- Villanova N, Bazzoli F, Taroni F, et al. Gallstone recurrence after successful oral bile acid treatment. Gastroenterology 1989; 97: 726–31
- Smith B F., LaMont J T. Gallstone prevention by alteration of gallbladder mucin secretion via prostaglandin synthesis inhibition. Gallstone disease. Pathophysiology and therapeutic approaches, W Swobodnik, H Ditschuneit, R D. Soloway. Springer Verlag, Berlin 1990; 231–5
- Carey M C. Formation of cholesterol gallstones: the new paradigms. Trends in bile acid research, G Paumgartner, A Stiehl, W Gerok. Kluwer Academic Publishers, London 1989; 259–81
- Mendez-Sanchez N, Lizardi-Cervera J, Moran S, et al. Cholesterol gallstones and aspirin. Gastroenterology 1992; 103: 1369–70
- Lee S P. Lessons from experimental cholelithiasis: gallbladder and mucosa, nonsteroidal antiinflammatory drugs, and gallstones. Gastroenterology 1991; 101: 857–60
- Uribe M, Kethenhoffen W, Sanchez J M., et al. Prevention of gallstone recurrence after extracorporeal biliary lithotripsy. Non-steroidal antiinflammatory drugs or ursodeoxycholic acid?. Gastroenterology 1991; 100: A807
- Cohen B I., Mosbach E H., Nariman A, et al. Aspirin does not inhibit cholesterol cholelithiasis in two established animal models. Gastroenterology 1991; 101: 1109–16
- LaMorte W W., O'Leary D P., Scott T E., et al. Inhibition of prostaglandin synthesis fails to prevent gallbladder mucin secretion or gallstone nucleation in the cholesterol-fed prairie dog. Gastroenterology 1990; 98: A253
- Rhodes M, Allen A, Dowling R H., et al. Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy. Gut 1992; 33: 1113–7
- Sackmann M, Ippisch E, Niller H, et al. Rezidivsteinrate nach StoBwellentherapie von Gallenblasensteinen. Z Gastroenterol 1991; 29: A563
- Rhodes M, Zijlstra F J., Bradburn D M., et al. Concentration of gallbladder bile mucin is reduced by nicotine. Gut 1992; 33: S26, Suppl 1
- Berr F, Sackmann M, Mayer M, et al. Faktoren für die Ent-stehung von Gallensteinrezidiven. Z Gastroenterol 1991; 29: A564